Abstract
Objective: To explore the disease management methods and effects for patients with inflammatory bowel disease (IBD) in the special period of pandemic. Methods: Medical staffs carried out the management of patients with IBD on the inflammatory disease service platform of this center from February to May of 2020 in addition to routine clinical works. Results: None of the nearly 3000 IBD patients who are being followed up at our center were infected with COVID-19. During this period, no patients experienced drug-related serious side effects or disease recurrence that could not be treated in time due to failure to reach the medical staffs. Conclusion: The disease management methods based on IBD platform allow the patients to be properly managed during this special period.
Highlights
In December 2019, SARS-CoV-2 outbroke in the world
None of the nearly 3000 inflammatory bowel disease (IBD) patients who are being followed up at our center were infected with COVID-19
The disease management methods based on IBD platform allow the patients to be properly managed during this special period
Summary
In December 2019, SARS-CoV-2 outbroke in the world. The whole population is generally susceptible to this highly contagious virus. It can cause COVID-19, fever and respiratory symptoms, and possibly gastrointestinal symptoms [1]. Inflammatory bowel disease (IBD) is a chronic non-specific intestinal inflammatory disorder. There is no cure for this lifelong disease. In addition to repeated attacks, complications, such as intestinal obstruction and fistula, are common. The compromised body’s resistance increased susceptibility to concomitant opportunistic infections.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
